Active, not recruitingNCT02461459

Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)

Studying Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Boston Children's Hospital
Principal Investigator: Darcy Krueger, MD, PhD, MD
Children's Hospital Medical Center, Cincinnati
Enrollment: 205 enrolled
Eligibility: All sexes
Timeline: 2015 – 2026

Study locations (6)

University of Alabama at Birmingham, Birmingham, Alabama, United States
University of California at Los Angeles, Los Angeles, California, United States
Stanford University, Palo Alto, California, United States
Boston Children's Hospital, Boston, Massachusetts, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
University of Texas at Houston, Houston, Texas, United States

Collaborators

National Institutes of Health (NIH) · National Institute of Neurological Disorders and Stroke (NINDS) · Tuberous Sclerosis Alliance · National Center for Advancing Translational Sciences (NCATS) · Office of Rare Diseases (ORD) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02461459 on ClinicalTrials.gov

Other trials for Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis →

← Back to all trials